Kalvista Pharmaceuticals Inc (KALV)
Retained Earnings
-$762.69M
Quarterly · Period ending: · USD
KALV Retained Earnings
Latest reported-$762.69Mperiod ending
Latest reported-$762.69Mperiod ending
KALV Quarterly Retained Earnings (-$34.42M → -$762.69M)
Quarterly retained earnings
High-resolution chart · PNG
KALV retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -762,694,000 | |
| -762,694,000 | |
| -739,098,000 | |
| -713,266,000 | |
| -653,170,000 | |
| -600,946,000 | |
| -552,437,000 | |
| -510,169,000 | |
| -469,726,000 | |
| -425,077,000 | |
| -396,049,000 | |
| -368,399,000 | |
| -343,082,000 | |
| -316,777,000 | |
| -295,474,000 | |
| -273,217,000 | |
| -250,175,000 | |
| -226,062,000 | |
| -203,595,000 | |
| -183,945,000 | |
| -167,836,000 | |
| -152,880,000 | |
| -142,832,000 | |
| -132,406,000 | |
| -121,592,000 | |
| -115,008,000 | |
| -105,717,000 | |
| -99,814,000 | |
| -92,476,000 | |
| -83,950,000 | |
| -79,994,000 | |
| -76,690,000 | |
| -71,660,000 | |
| -71,003,000 | |
| -65,769,000 | |
| -60,784,000 | |
| -55,855,000 | |
| -51,653,000 | |
| -88,963,000 | |
| -86,577,000 | |
| -79,228,000 | |
| -72,621,000 | |
| -66,962,000 | |
| -61,971,000 | |
| -52,959,000 | |
| -47,775,000 | |
| -43,061,000 | |
| -34,416,000 |